Broadly neutralizing antibodies to SARS-CoV-2 provide novel insights into the neutralization of variants and other human coronaviruses
P Bajpai, V Singh, A Chandele… - Frontiers in Cellular and …, 2022 - frontiersin.org
Seven coronaviruses are known to cause infection/disease in humans. Of these, human
coronavirus (HCoV)-229E and HCoV-NL63 are alphacoronaviruses (α-CoVs), whereas …
coronavirus (HCoV)-229E and HCoV-NL63 are alphacoronaviruses (α-CoVs), whereas …
Nanobody derived using a peptide epitope from the spike protein receptor-binding motif inhibits entry of SARS-CoV-2 variants
N Mendon, RA Ganie, S Kesarwani, D Dileep… - Journal of Biological …, 2023 - ASBMB
The emergence of new escape mutants of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has escalated its penetration among the human population …
coronavirus 2 (SARS-CoV-2) has escalated its penetration among the human population …
[图书][B] Artificial Intelligence and machine learning in drug design and development
The book is a comprehensive guide that explores the use of artificial intelligence and
machine learning in drug discovery and development covering a range of topics, including …
machine learning in drug discovery and development covering a range of topics, including …
AI‐Based Personalized Drug Treatment
M Shanmuga Sundari, HR Penthala… - … Machine Learning in …, 2024 - Wiley Online Library
Precision medicine, also known as AI‐based personalized drug therapy, seeks to tailor
treatment plans for individuals based on their genetics, medical history, lifestyle, and more …
treatment plans for individuals based on their genetics, medical history, lifestyle, and more …
Process and Applications of Structure‐Based Drug Design
M Shanmuga Sundari, SA Thotakura… - … Machine Learning in …, 2024 - Wiley Online Library
Structure‐based drug design (SBDD) is a methodology used in drug discovery to design
and develop new drugs based on the three‐dimensional structure of the biological target …
and develop new drugs based on the three‐dimensional structure of the biological target …
Peptide derived nanobody inhibits entry of SARS-CoV-2 variants
N Mendon, R Ganie, S Kesarwani, D Dileep, S Sasi… - bioRxiv, 2022 - biorxiv.org
Emergence of the new escape mutants of the SARS-CoV-2 virus has escalated its
penetration among the human population and has reinstated its status as a global …
penetration among the human population and has reinstated its status as a global …